SCHEMBL12379800

SCHEMBL12379800

CCCCCNC(=O)c1nc(Cl)c(N)nc1N

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCNN1A P37088 8/20 0.60
KCNH2 Q12809 2/20 0.46
GRM5 P41594 1/20 0.43
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 5/20 0.43
HPGD P15428 5/20 0.43
HSD17B10 Q99714 5/20 0.43
LMNA P02545 4/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2D6 P10635 3/20 0.43
NFKB1 P19838 2/20 0.43
THPO P40225 2/20 0.43
HIF1A Q16665 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GMNN O75496 2/20 0.43
PMP22 Q01453 2/20 0.43
CYP3A4 P08684 1/20 0.43
STAT6 P42226 1/20 0.43
RECQL P46063 1/20 0.43
NAAA Q02083 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16541800 0.89 SCNN1A (0.53) SCNN1AKCNH2GRM5ALDH1A1KDM4E
SCHEMBL829702 0.87 SCNN1A (0.59) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14190122 0.86 SCNN1A (0.61) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13090579 0.86 SCNN1A (0.61) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14190128 0.86 SCNN1A (0.61) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13090581 0.86 SCNN1A (0.61) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14088251 0.86 SCNN1A (0.61) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14190132 0.86 SCNN1A (0.61) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14190133 0.86 SCNN1A (0.61) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12433373 0.86 SCNN1A (0.61) SCNN1AALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201625-A1 Organic Comopunds NOVARTIS AG (CH) 2011-08-18 US disclosed
US-20110201625-A1 Organic Comopunds NOVARTIS AG (CH) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201625-A1 Organic Comopunds OR10J3, CFTR, CLIC1 SCNN1A 52/4885KCNH2 49/4885GRM5 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.